Symbol="MDGL"
AssetType="Common Stock"
Name="Madrigal Pharmaceuticals Inc"
Description="Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic and liver diseases. The company is headquartered in West Conshohocken, Pennsylvania."
CIK="1157601"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="200 BARR HARBOR DRIVE, SUITE 400, WEST CONSHOHOCKEN, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="3316873000"
EBITDA="-329996992"
PERatio="None"
PEGRatio="0"
BookValue="5.61"
DividendPerShare="0"
DividendYield="0"
EPS="-18.6"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.796"
ReturnOnEquityTTM="-3.526"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-18.6"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="325.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="93.6"
EVToRevenue="-"
EVToEBITDA="-3.293"
Beta="-0.761"
num_52WeekHigh="322.67"
num_52WeekLow="57.21"
num_50DayMovingAverage="213.11"
num_200DayMovingAverage="226.64"
SharesOutstanding="18471200"
DividendDate="2016-07-25"
ExDividendDate="None"
symbol="MDGL"
open="178.87"
high="184.73"
low="174.05"
price="180.89"
volume="167909.00"
latest_trading_day="2023-08-22"
previous_close="179.37"
change="1.52"
change_percent="0.8474%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="57"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="43"
Volume_recent_avg="333837"
Change_recent_avg="-0.56"
Delta_recent_avg="11.84"
Variance_recent_avg="5.92"
Change_ratio_recent_avg="-0.3"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="43"
Aroon_momentum_negative="57"
image_negative_thumbnail_id_1="1165"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0199.jpeg"
image_negative_thumbnail_id_2="150"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0026.jpeg"
image_neutral_thumbnail_id_1="537"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0062.jpeg"
image_neutral_thumbnail_id_2="594"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0005.jpeg"
image_positive_thumbnail_id_1="621"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0087.jpeg"
image_positive_thumbnail_id_2="668"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0040.jpeg"
image_professor_thumbnail_id_1="1177"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
image_professor_thumbnail_id_2="1173"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
